Citadel Advisors
NIVF

Citadel Advisors’s NewGenIvf NIVF Stock Holding History

Citadel Advisors’s Portfolio NIVF Stock Details NIVF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$15.9K – 15510
2025
Q1 		$15.9K Buy
+3
New +$87.3K ﹤0.01% 13302

Other funds holding NIVF

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citadel Advisors's NIVF Position: Q2 2025 in Review

Citadel Advisors sold out of NewGenIvf (NIVF) in Q2 2025, closing a stake of 3 shares — an estimated $15.9K sold.

Citadel Advisors first reported a position in NIVF in Q1 2025 and held it in 1 quarter. The position peaked at $15.9K in Q1 2025. 1 fund tracked by Wall St. Rank holds NIVF as of Q2 2025.

  • Citadel Advisors reported no remaining NewGenIvf position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 3 NewGenIvf shares in Q2 2025, an estimated $15.9K.
  • Citadel Advisors first reported a position in NewGenIvf in Q1 2025 and held it in 1 quarter.
  • Citadel Advisors's NewGenIvf position peaked at $15.9K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held NewGenIvf as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.